Botulinum Toxin B

@article{Figgitt2012BotulinumTB,
  title={Botulinum Toxin B},
  author={D. Figgitt and S. Noble},
  journal={Drugs},
  year={2012},
  volume={62},
  pages={705-722}
}
  • D. Figgitt, S. Noble
  • Published 2012
  • Medicine
  • Drugs
  • SummaryAbstractBotulinum toxins are well known as the causative agents of human botulism food poisoning. However, in the past two decades they have become an important therapeutic mainstay in the treatment of dystonias including cervical dystonia, a neurological disorder characterised by involuntary contractions of the cervical and/or shoulder muscles. The toxins inhibit acetylcholine release from neuromuscular junctions, producing muscle weakness when injected into dystonic muscles.Data from… CONTINUE READING
    3 Citations

    References

    SHOWING 1-10 OF 80 REFERENCES
    Botulinum toxin: from poison to remedy.
    • 65
    • Highly Influential
    Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
    • 407
    • Highly Influential
    Development of resistance to botulinum toxin type A in patients with torticollis
    • 332
    Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
    • 182
    • Highly Influential
    Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia
    • 221
    • Highly Influential
    Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology.
    • 26
    • Highly Influential
    Botulinum toxin therapy, immunologic resistance, and problems with available materials
    • 185
    • PDF
    Response and immunoresistance to botulinum toxin injections
    • 300
    • Highly Influential
    Therapeutic uses of botulinum toxin.
    • 746
    • Highly Influential